Drug Manufacturers Gaining Superb Volume: (NYSE:MRK), (NYSE:PFE), (NYSE:JNJ), (NYSE:BMY)
Houston, TX – December 21, 2012 — (Net PR News) – AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s Stocks in focus are: MRK, PFE, JNJ, BMY
Merck & Co., Inc. (NYSE:MRK) was among the Drug Manufacturers industry volume actives which traded most effectively. The number of shares traded in the prior session were 33,605,100 while its average volume stayed 11.66 million.
Merck & Co., Inc. (NYSE:MRK) announced that the HPS2-THRIVE study of TREDAPTIVE™ did not to meet up to its key endpoint. MRK, as well as the investigators, are notifying regulatory agencies regarding these results.
How Should Investors Trade MRK Now? Don’t Trade MRK Until You Read This TREND ANALYSIS REPORT
Pfizer Inc. (NYSE: PFE) gained in the trading session of December 20, 2012 +0.32%. The 52 week range of PFE was $20.75 – $26.09 while the market capitalization was $187.23 billion.
The beta of PFE was 0.69.
Pfizer Inc. (NYSE:PFE) has intended to host a conference call with investment analysts at 10 A.M. Eastern Time on Tuesday, January 29, 2013. The company encourages investors and other interested parties to listen to a webcast of the conference event.
The main motive of the conference call is to review PFE’s Q4 of 2012 financial results.
The general public will be able to participate in the event by visiting the company’s website’s investor’s presentation tab and by clicking the link of PFE Quarterly Corporate Performance Q4 2012.
Interested parties will also be able to listen to the conference call by dialing (866) 246-2545 in the U.S. as well as Canada.
How Should Investors React To PFE Now? Find Out In This TREND ANALYSIS REPORT
Johnson & Johnson (NYSE:JNJ) stock started the trading session on December 20, 2012 with the price of $70.74 and closed at the end of the day at $70.75.
JNJ advanced +0.17%. The 52 week price range of JNJ remained $61.71 – $72.74 and the market capitalization was of $196.07 billion.
JNJ traded with strong volume of 11,628,000 shares in the prior trading session.
Get A Free Report And Detailed Analysis On JNJ CLICK HERE To Read
Bristol Myers Squibb Co. (NYSE:BMY) traded with the opening price of $32.53, hit the high price of the day at $32.63 and closed the last trading session at $32.57.
BMY’s weekly and monthly performances remained -0.67% and +1.31%, respectively.
Is BMY A Solid Investment At These Levels? Find Out Exactly Where BMY Is Headed With This TREND ANALYSIS REPORT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.